SPARX BIOPHARMACEUTICAL CORP Employee Directory
Pharmaceutical ManufacturingIllinois, United States11-50 Employees
SparX Biopharmaceutical Corp. is a research-based development-stage biopharmaceutical company focused on immuno-oncology, aiming to strengthen human immunity through antibody therapies. It leverages large-scale data analysis and mechanistic pharmacology, conducting in vitro and in vivo evaluations to identify novel or superior therapeutics. Based in Mount Prospect, Illinois, the company operates as a small to mid-sized enterprise with in-house cGMP facilities capable of producing clinical and commercial drug products. SparX pursues an integrated approach to antibody drug development, combining target discovery with antibody optimization and bi-ADC strategies to improve the probability of success. In recent developments, the company attended AACR 2025 and planned to present Phase 1 clinical updates of SPX-303, a dual-checkpoint bispecific antibody. The organization aims to become an integrated, independent biopharmaceutical company.